Risk of death following SARS-CoV-2 infection or COVID-19 vaccination in young people in England: a self-controlled case series study

This research has not been peer-reviewed. It is a preliminary report that should not be regarded as conclusive, guide clinical practice or health-related behaviour, or be reported in news media as established information.

Objectives 

To assess whether there is a change in the incidence of cardiac and all-cause death in young people following COVID-19 vaccination or SARS-CoV-2 infection in unvaccinated individuals.

Design 

Self-controlled case series.

Setting 

National, linked electronic health record data in England.

Study population 

Individuals aged 12-29 who had received at least one dose of COVID-19 vaccination and died between 8 December 2020 and 2 February 2022 and registered by 16 February 2022 within 12 weeks of COVID-19 vaccination; Individuals aged 12-29 who died within 12 weeks of testing positive for SARS-CoV-2.

Main outcome measures 

Cardiac and all-cause deaths occurring within 12 weeks of vaccination or SARS-CoV-2 infection.

Results 

Compared to the baseline period, there was no evidence of a change in the incidence of cardiac death in the six weeks after vaccination, whether for each of weeks 1 to 6 or the whole six-week period. There was a decrease in the risk of all-cause death in the first week after vaccination and no change in each of weeks 2 to 6 after vaccination or whole six-week period after vaccination. Subgroup analyses by sex, age, vaccine type, and last dose also showed no change in the risk of death in the first six weeks after vaccination. There was a large increase in the incidence of cardiac and all-cause death in the overall risk period after SARS-CoV-2 infection among the unvaccinated.

Conclusion There is no evidence of an association between COVID-19 vaccination and an increased risk of death in young people. By contrast, SARS-CoV-2 infection was associated with substantially higher risk of cardiac related death and all-cause death.

Author list

Vahé Nafilyan, Charlotte Bermingham, Isobel L. Ward, Jasper Morgan, Francesco Zaccardi, Kamlesh Khunti, Julie Stanborough, Amitava Banerjee

Novel Coronavirus SARS-CoV-2

10.1101/2022.03.22.22272775

MedRxiv